Anxiety symptoms and disease severity in children and adolescents with crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 60, Issue 1, 2015, Pages 30-35

  Reigada, Laura C ^a   Hoogendoorn, Claire J ^a   Walsh, Lindsay C ^a   Lai, Joanne ^b   Szigethy, Eva ^c   Cohen, Barry H ^d   Bao, Ruijun ^b   Isola, Kimberly ^b   Benkov, Keith J ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

abdominal pain; anxiety; Crohn disease; pediatrics

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ANXIETY DISORDER; ARTICLE; ASSESSMENT OF HUMANS; CHILD; CROHN DISEASE; DISTRESS SYNDROME; FEMALE; GENERALIZED ANXIETY DISORDER; HARVEY BRADSHAW INDEX; HUMAN; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANIC ANXIETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL ANXIETY; SCREEN FOR CHILD ANXIETY RELATED DISORDER SCORE; SELF REPORT; SEPARATION ANXIETY; SOMATIC ANXIETY; WELLBEING; AMBULATORY CARE; ANXIETY; DIAGNOSIS; DIARRHEA; EPIDEMIOLOGY; HUMANS; INCIDENCE; MEDICAL RECORDS; NEW YORK CITY; PHYSIOPATHOLOGY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGY; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS;

ABDOMINAL PAIN; ADOLESCENT; AMBULATORY CARE; ANXIETY; CHILD; CROHN DISEASE; DIARRHEA; FEMALE; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; NEW YORK CITY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISK; SELF REPORT; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS;

EID: 84920744201     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000552     Document Type: Article

References (49)

1. Pao M, Bosk A. Anxiety in medically ill children/adolescents. Depress Anxiety 2011;28:40-9.
2. Bernstein CM, Stockwell MS, Gallagher MP, et al. Mental health issues in adolescents and young adults with type 1 diabetes prevalence and impact on glycemic control. Clin Pediatr 2013;52:10-5.
3. Bregnballe V, Thastum M, Schiotz PO. Psychosocial problems in children with cystic fibrosis. Acta Pædiatr 2007;96:58-61.
4. Chavira DA, Garland AF, Daley S, et al. The impact of medical comorbidity on mental health and functional health outcomes among children with anxiety disorders. J Dev Behav Pediatr 2008;29:394.
5. Kashikar-Zuck S, Parkins IS, Graham TB, et al. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain 2008;24:620-6.
6. McCauley E, KatonW, Russo J, et al. Impact of anxiety and depression on functional impairment in adolescents with asthma. Gen Hosp Psychiatry 2007;29:214-22.
7. Loftus EV, Guerin A, Yu AP, et al. Increased risks of developing anxiety and depression in young patients with Crohn's disease. Am J Gastroenterol 2011;106:1670-7.
8. Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in ireland. J Pediatr Gastroenterol Nutr 2011;53:275-9.
9. Reigada L, Masia Warner C, Benkov K, et al. Cognitive-behavioral treatment for youth with IBD and co-morbid anxiety disorders: results of an open pilot. Inflamm Bowel Dis 2011;17:S58.
10. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105-18.
11. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987;28:1600-4.
12. Maunder RG, Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr Mol Med 2008;8:247-52.
13. Nelemans SA, HaleWW, Branje SJ, et al. Heterogeneity in development of adolescent anxiety disorder symptoms in an 8-year longitudinal community study. Dev Psychopathol 2013:1-22.
14. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007;13:225-34.
15. North CS, Alpers DH. A review of studies of psychiatric factors in Crohn's disease: etiologic implications. Ann Clin Psychiatry 1994;6:S43-5.
16. Ondersma SJ, Lumley MA, Corlis ME, et al. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol 1997;22:723-38.
17. Wood B, Watkins JB, Boyle JT, et al. Psychological functioning in children with Crohn's disease and ulcerative colitis: Implications for models of psychobiological interaction. J Am Acad Child Adolesc Psychiatry 1987;26:774-81.
18. Harvey R, Bradshaw J. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
19. Birmaher B, Brent DA, Chiappetta L, et al. Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study. JAm Acad Child Adolesc Psychiatry 1999;38:1230-6.
20. Stevanovic D, Jancic J, Lakic A. The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 2011;52:e75-8.
21. Wren FJ, Berg EA, Heiden LA, et al. Childhood anxiety in a diverse primary care population: parent-child reports, ethnicity and SCARED factor structure. J Am Acad Child Adolesc Psychiatry 2007;46:332-40.
22. Reigada LC, Benkov KJ, Bruzzese J, et al. Integrating illness concerns into cognitive behavioral therapy for children and adolescents with inflammatory bowel disease and co-occurring anxiety. J Spec Pediatr Nurs 2013;18:133-43.
23. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007;132:52-65.
24. Felipez LM, Gokhale R, Tierney MP, et al. Thalidomide use and outcomes in pediatric patients with Crohn's disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr 2012;54:28-33.
25. Min SB, Le-Carlson M, Singh N, et al. Video capsule endoscopy impacts decision making in pediatric IBD: A single tertiary care center experience. Inflamm Bowel Dis 2013;19:2139-45.
26. Weiss B, Lerner A, Shapiro R, et al. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues. J Pediatr Gastroenterol Nutr 2009;48:526-30.
27. Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis 2011;17:2521-6.
28. Cohen BH. Explaining Psychological Statistics. 4th ed. New York: Wiley; 2013:412.
29. Beesdo K. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am 2009;32:483-524.
30. Mackner LM, Crandall WV, Szigethy EM. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr 2007; 19:548-52.
31. SpillerR,AzizQ,CreedF, et al.Guidelineson the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98.
32. Campo JV, Bridge J, Ehmann M, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics 2004;113:817-24.
33. Gros DF, Antony MM, McCabe RE, et al. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord 2009;23:290-6.
34. CrandallWV, Halterman TE, Mackner LM. Anxiety and pain symptoms in children with inflammatory bowel disease and functional gastrointestinal disorders undergoing colonoscopy. J Pediatr Gastroenterol Nutr 2007;44:63-7.
35. Hofflich SA, Hughes AA, Kendall PC. Somatic complaints and childhood anxiety disorders. Int J Clin Health Psychol 2006;6:229.
36. Walker EA, Gelfand MD, Gelfand AN, et al. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry 1996;18:220-9.
37. Rabbett H, Elbadri A, Thwaites R, et al. Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:528-33.
38. Egger HL, Costello EJ, Angold A. School refusal and psychiatric disorders: a community study. J Am Acad Child Adolesc Psychiatry 2003;42:797-807.
39. Kearney CA, Albano AM. The functional profiles of school refusal behavior diagnostic aspects. Behav Modif 2004;28:147-61.
40. Williams LJ, Pasco JA, Jacka FN, et al. Pain and the relationship with mood and anxiety disorders and psychological symptoms. J Psychosom Res 2012;72:452-6.
41. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003;106:127-33.
42. Thompson RD, Delaney P, Flores I, et al. Cognitive-behavioral therapy for children with comorbid physical illness. Child Adolesc Psychiatr Clin N Am 2011;20:329-48.
43. Klein RG, Pine DS. Anxiety disorders. In: Rutter M, Taylor E, eds. Child and Adolescent Psychiatry: Modern Approaches. London: Blackwell Scientific; 2002:486-509.
44. Häuser W, Moser G, Klose P, et al. Psychosocial issues in evidencebased guidelines on inflammatory bowel diseases: a review. World J Gastroenterol 2014;20:3663.
45. Lee GJ, Kappelman MD, Boyle B, et al. Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:701-6.
46. Axelson DA, Birmaher B. Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001;14:67-78.
47. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 2004;49:492-7.
48. Sandler RS, Jordan MC, Kupper LL. Development of a Crohn's index for survey research. J Clin Epidemiol 1988;41:451-8.
49. Kappelman MD, Crandall WV, Colletti RB, et al. Short pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis 2011;17:112-7.